PM, MO, BTI, TPB: Tobacco Stocks Surge as FDA Greenlights Nicotine Pouches - What’s Next for Investors?

Big Tobacco just caught a regulatory break—and investors are lighting up.

The FDA's latest nicotine pouch update sent shockwaves through tobacco equities, with PM, MO, BTI, and TPB all posting significant moves. The announcement effectively opens new revenue streams for an industry desperate to pivot beyond traditional cigarettes.

Market Mechanics

Nicotine pouches represent the sector's attempt to reinvent itself—smoke-free, discreet, and riding the wellness-adjacent wave. Regulatory clarity removes a major overhang that's kept institutional money on the sidelines.

Execution Risk

But don't pop the champagne yet. These stocks carry baggage—litigation risks, declining cigarette volumes, and now the pressure to execute flawlessly in a brand-new category. One cynical trader noted, 'They'll probably miss guidance and blame the FDA anyway.'

The real test? Whether management can innovate faster than regulators can restrict.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Philip Morris International (PM), Altria (MO), British American Tobacco (BTI), and Turning Point Brands (TPB) are among the tobacco companies with nicotine pouches in line for review at the FDA. Philip Morris International’s Zyn pouches are already on the market, but its updated Zyn Ultra pouches have yet to be cleared for sale by the FDA. These Zyn Ultra pouches WOULD be included in the fast-track review program.

Tobacco Stocks Movement Today

Shares of tobacco companies’ stocks saw varied movement alongside today’s FDA news. Let’s get into that below:

• Philip Morris International stock was up 0.25% during pre-market trading.
• Altria stock slipped slightly before the opening bell.
• British American Tobacco increased over 1% in early morning trading.
• Turning Point Brands stock jumped just over 2% before markets opened.

While today’s movement comes from reports, an official announcement could act as an additional catalyst for these shares. Investors will want to keep an eye on the FDA to see what it has to say about nicotine pouches in the days to come.

Which Nicotine Pouch Maker Do Analysts’ Prefer?

Turning to the TipRanks’ stock comparison tool, traders can get an idea of which nicotine stock analysts favor. Philip Morris and Turning Point Brands lead the group with consensus Strong Buy ratings, while Altria has a Hold rating, and British American Tobacco has a Moderate Sell rating. PM stock has the highest upside potential at 20.14%, followed by TPB at 4.06%. MO and BTI have downside potentials.